• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒介导的 REIC/Dkk-3 基因治疗在胰腺癌治疗中的应用潜力。

Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.

机构信息

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

出版信息

J Gastroenterol Hepatol. 2014 May;29(5):973-83. doi: 10.1111/jgh.12501.

DOI:10.1111/jgh.12501
PMID:24372695
Abstract

BACKGROUND AND AIM

The reduced expression in immortalized cells REIC/the dickkopf 3 (Dkk-3) gene, tumor suppressor gene, is downregulated in various malignant tumors. In a prostate cancer study, an adenovirus vector carrying the REIC/Dkk-3 gene (Ad-REIC) induces apoptosis. In the current study, we examined the effects of REIC/Dkk-3 gene therapy in pancreatic cancer.

METHODS

REIC/Dkk-3 expression was assessed by immunoblotting and immunohistochemistry in the pancreatic cancer cell lines (ASPC1, MIAPaCa2, Panc1, BxPC3, SUIT-2, KLM1, and T3M4) and pancreatic cancer tissues. The Ad-REIC agent was used to investigate the apoptotic effect in vitro and antitumor effects in vivo. We also assessed the therapeutic effects of Ad-REIC therapy with gemcitabine.

RESULTS

The REIC/Dkk-3 expression was lost in the pancreatic cancer cell lines and decreased in pancreatic cancer tissues. Ad-REIC induced apoptosis and inhibited cell growth in the ASPC1 and MIAPaCa2 lines in vitro, and Ad-REIC inhibited tumor growth in the mouse xenograft model using ASPC1 cells. The antitumor effect was further enhanced in combination with gemcitabine. This synergistic effect may be caused by the suppression of autophagy via the enhancement of mammalian target of rapamycin signaling.

CONCLUSIONS

Ad-REIC induces apoptosis and inhibits tumor growth in pancreatic cancer cell lines. REIC/Dkk-3 gene therapy is an attractive therapeutic tool for pancreatic cancer.

摘要

背景与目的

抑癌基因 REIC/ Dickkopf-3(Dkk-3)在永生化细胞中的表达减少,其在多种恶性肿瘤中下调。在一项前列腺癌研究中,携带 REIC/Dkk-3 基因的腺病毒载体(Ad-REIC)可诱导细胞凋亡。在本研究中,我们检测了 REIC/Dkk-3 基因治疗对胰腺癌的影响。

方法

采用免疫印迹和免疫组化法检测胰腺癌细胞系(ASPC1、MIAPaCa2、Panc1、BxPC3、SUIT-2、KLM1 和 T3M4)和胰腺癌组织中 REIC/Dkk-3 基因的表达。采用 Ad-REIC 试剂检测体外的凋亡效应及体内的抗肿瘤效应。我们还评估了与吉西他滨联合应用 Ad-REIC 治疗的疗效。

结果

REIC/Dkk-3 的表达在胰腺癌细胞系中缺失,并在胰腺癌组织中减少。Ad-REIC 在体外诱导 ASPC1 和 MIAPaCa2 细胞系发生凋亡和抑制细胞生长,并且在使用 ASPC1 细胞的小鼠异种移植模型中抑制肿瘤生长。与吉西他滨联合应用可增强抗肿瘤作用。这种协同作用可能是通过增强雷帕霉素靶蛋白信号转导来抑制自噬所致。

结论

Ad-REIC 诱导胰腺癌细胞系发生凋亡并抑制肿瘤生长。REIC/Dkk-3 基因治疗是一种有吸引力的胰腺癌治疗工具。

相似文献

1
Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.腺病毒介导的 REIC/Dkk-3 基因治疗在胰腺癌治疗中的应用潜力。
J Gastroenterol Hepatol. 2014 May;29(5):973-83. doi: 10.1111/jgh.12501.
2
Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.新型REIC/Dkk-3编码腺病毒载体作为一种有前景的胰腺癌治疗药物。
Cancer Gene Ther. 2016 Aug;23(8):278-83. doi: 10.1038/cgt.2016.31. Epub 2016 Jul 29.
3
Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.一种新型的在永生化细胞中低表达/表达Dickkopf-3的腺病毒载体对肝细胞癌具有有前景的治疗效果。
J Gastroenterol Hepatol. 2017 Oct;32(10):1769-1777. doi: 10.1111/jgh.13757.
4
Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.腺病毒载体介导的 REIC/Dkk-3 基因治疗胆管癌的研究进展。
Curr Gene Ther. 2020;20(1):64-70. doi: 10.2174/1566523220666200309125709.
5
A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.一种超基因表达系统增强了腺病毒介导的 REIC/Dkk-3 基因治疗抗神经胶质瘤的作用。
Sci Rep. 2016 Sep 14;6:33319. doi: 10.1038/srep33319.
6
Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.REIC/Dkk-3 编码腺病毒载体治疗非小细胞肺癌的抗癌作用。
PLoS One. 2014 Feb 3;9(2):e87900. doi: 10.1371/journal.pone.0087900. eCollection 2014.
7
Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.整合素拮抗剂增强腺病毒介导的REIC/Dkk-3基因疗法对恶性胶质瘤的治疗效果。
Gene Ther. 2015 Feb;22(2):146-54. doi: 10.1038/gt.2014.100. Epub 2014 Nov 13.
8
REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.REIC/Dkk-3过表达下调多药耐药MCF7/ADR细胞中的P-糖蛋白并诱导乳腺癌细胞凋亡。
Cancer Gene Ther. 2009 Jan;16(1):65-72. doi: 10.1038/cgt.2008.58. Epub 2008 Jul 25.
9
A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.一种新型基因表达系统可显著增强编码REIC/Dkk-3的腺病毒载体的抗癌效果。
Oncol Rep. 2014 Mar;31(3):1089-95. doi: 10.3892/or.2013.2958. Epub 2013 Dec 31.
10
REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.携带 REIC/Dkk-3 基因的腺病毒载体作为膀胱癌潜在有效治疗药物。
Int J Oncol. 2012 Aug;41(2):559-64. doi: 10.3892/ijo.2012.1503. Epub 2012 May 31.

引用本文的文献

1
Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells.REIC/Dkk-3 蛋白在癌细胞中 PD-L1 调控的新型细胞外作用。
J Mol Med (Berl). 2023 Apr;101(4):431-447. doi: 10.1007/s00109-023-02292-w. Epub 2023 Mar 4.
2
Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy.工程化溶瘤腺病毒:一种新兴的癌症治疗方法。
Pathogens. 2022 Oct 4;11(10):1146. doi: 10.3390/pathogens11101146.
3
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.
扩大对基于水疱性口炎病毒的溶瘤病毒疗法有反应的胰腺癌谱:挑战与解决方案
Cancers (Basel). 2021 Mar 9;13(5):1171. doi: 10.3390/cancers13051171.
4
Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice.人羊膜间充质干细胞抑制荷瘤小鼠的肝癌。
J Cell Mol Med. 2020 Sep;24(18):10525-10541. doi: 10.1111/jcmm.15668. Epub 2020 Aug 14.
5
A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients.GATA4 增强的肿瘤抑制模块为 GATA4 缺乏的 HCC 患者提供了治疗机会。
Theranostics. 2020 Jan 1;10(2):484-497. doi: 10.7150/thno.38060. eCollection 2020.
6
Dickkopf Homolog 3 Acts as a Potential Tumor Suppressor in Gallbladder Cancer.Dickkopf 同源物 3 在胆囊癌中作为一种潜在的肿瘤抑制因子发挥作用。
Front Oncol. 2019 Oct 29;9:1121. doi: 10.3389/fonc.2019.01121. eCollection 2019.
7
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.抑制基质衍生的 Dickkopf-3(DKK3)可抑制胰腺导管腺癌的肿瘤进展并延长生存期。
Sci Transl Med. 2018 Oct 24;10(464). doi: 10.1126/scitranslmed.aat3487.
8
The role of Dickkopf family in cancers: from Bench to Bedside.Dickkopf家族在癌症中的作用:从实验室到临床应用
Am J Cancer Res. 2017 Sep 1;7(9):1754-1768. eCollection 2017.
9
A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.Dickkopf相关蛋白3在人膀胱癌T24细胞巨吞饮作用中的新作用
Int J Mol Sci. 2016 Nov 5;17(11):1846. doi: 10.3390/ijms17111846.
10
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.携带REIC/DKK-3基因的腺病毒载体:用于接受根治性前列腺切除术的高危局限性前列腺癌的新辅助前列腺内注射
Cancer Gene Ther. 2016 Nov;23(11):400-409. doi: 10.1038/cgt.2016.53. Epub 2016 Oct 21.